[
  {
    "ts": null,
    "headline": "ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?",
    "summary": "As the structural heart market expands, Abbott and Edwards battle for leadership. Which stock holds stronger growth momentum now?",
    "url": "https://finnhub.io/api/news?id=f99e9bc84f5ed48fb8e12e082c1568899c2eb8830bae89f09a0f8b231af02b0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756475280,
      "headline": "ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?",
      "id": 136569225,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "As the structural heart market expands, Abbott and Edwards battle for leadership. Which stock holds stronger growth momentum now?",
      "url": "https://finnhub.io/api/news?id=f99e9bc84f5ed48fb8e12e082c1568899c2eb8830bae89f09a0f8b231af02b0e"
    }
  },
  {
    "ts": null,
    "headline": "Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care",
    "summary": "MADRID, August 29, 2025--Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless of symptoms.",
    "url": "https://finnhub.io/api/news?id=85bddd6409f56a55aa0537d561440866e9eed422a83c674886294ef9c37d74e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756472940,
      "headline": "Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care",
      "id": 136569572,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "MADRID, August 29, 2025--Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless of symptoms.",
      "url": "https://finnhub.io/api/news?id=85bddd6409f56a55aa0537d561440866e9eed422a83c674886294ef9c37d74e4"
    }
  }
]